HRMY Competitors & Alternatives
Compare Harmony Biosciences Holdings with similar stocks in the same industry
Biotechnology
HRMY
Main Stock$35.54
Tradestie Score
57
Market Cap
$1.55B
P/E Ratio
14.9
Revenue Growth
0.2%
Analyst Upside
+26.4%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AGIO
Agios Pharmaceuticals, Inc.
|
$40.55
|
$2.33B | - | 59 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.30
|
$2.23B | - | 53 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.02
|
$2.22B | - | 59 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.29
|
$2.21B | - | 54 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$26.48
|
$2.18B | - | 64 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$16.22
|
$2.08B | - | 60 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.82
|
$2.02B | 54.1 | 57 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.02
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$37.46
|
$1.97B | - | 60 | Compare |
More HRMY Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry